About Cysteine sulfinic acid decarboxylase
Cysteine sulfinic acid decarboxylase (CSAD) is a protein
from Homo sapiens identified by UniProt accession
Q9Y600, 493 residues long.
MolForge cross-references it against 0 known binders and
65 disease associations.
Target properties
| Protein name | Cysteine sulfinic acid decarboxylase |
| UniProt accession | Q9Y600 |
| Gene | CSAD |
| Organism | Homo sapiens |
| Length | 493 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (65)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.50
- Alzheimer disease · score 0.28
- lysosomal storage disease · score 0.28
- Parkinson disease · score 0.28
- multiple sclerosis · score 0.28
- mathematical ability · score 0.18
- lymphocyte count · score 0.16
- type 1 diabetes mellitus · score 0.16
- self reported educational attainment · score 0.15
- non-alcoholic fatty liver disease · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9Y600-F1 | alphafold | PREDICTED | 96.51 | — |
Amino-acid sequence (493 residues)
MADSEALPSL AGDPVAVEAL LRAVFGVVVD EAIQKGTSVS QKVCEWKEPE ELKQLLDLEL RSQGESQKQI LERCRAVIRY SVKTGHPRFF NQLFSGLDPH ALAGRIITES LNTSQYTYEI APVFVLMEEE VLRKLRALVG WSSGDGIFCP GGSISNMYAV NLARYQRYPD CKQRGLRTLP PLALFTSKEC HYSIQKGAAF LGLGTDSVRV VKADERGKMV PEDLERQIGM AEAEGAVPFL VSATSGTTVL GAFDPLEAIA DVCQRHGLWL HVDAAWGGSV LLSQTHRHLL DGIQRADSVA WNPHKLLAAG LQCSALLLQD TSNLLKRCHG SQASYLFQQD KFYDVALDTG DKVVQCGRRV DCLKLWLMWK AQGDQGLERR IDQAFVLARY LVEEMKKREG FELVMEPEFV NVCFWFVPPS LRGKQESPDY HERLSKVAPV LKERMVKEGS MMIGYQPHGT RGNFFRVVVA NSALTCADMD FLLNELERLG QDL
Explore Cysteine sulfinic acid decarboxylase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets